Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Net Margin (2016 - 2025)

Historic Net Margin for Palisade Bio (PALI) over the last 14 years, with Q3 2025 value amounting to 57360.0%.

  • Palisade Bio's Net Margin changed N/A to 57360.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 140837.5%, marking a year-over-year change of. This contributed to the annual value of 5234.0% for FY2023, which is N/A changed from last year.
  • Per Palisade Bio's latest filing, its Net Margin stood at 57360.0% for Q3 2025.
  • In the past 5 years, Palisade Bio's Net Margin ranged from a high of 223000.0% in Q1 2025 and a low of 19688.46% during Q3 2021
  • Moreover, its 3-year median value for Net Margin was 4846.72% (2021), whereas its average is 57713.75%.
  • Data for Palisade Bio's Net Margin shows a peak YoY increase of 788867200bps (in 2021) and a maximum YoY decrease of 331002500bps (in 2021) over the last 5 years.
  • Palisade Bio's Net Margin (Quarter) stood at 19688.46% in 2021, then soared by 95bps to 936.0% in 2023, then skyrocketed by 6228bps to 57360.0% in 2025.
  • Its Net Margin stands at 57360.0% for Q3 2025, versus 139200.0% for Q2 2025 and 223000.0% for Q1 2025.